Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-11 Sale |
2025-03-13 6:33 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
1,773 | $21.96 | $38,940 | 16,288 (Indirect Direct) |
View |
| 2024-09-11 Sale |
2024-09-13 6:26 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
909 | $11.64 | $10,580 | 17,861 (Indirect Direct) |
View |
| 2024-03-11 Sale |
2024-03-12 9:48 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
21,029 | $0.6698 | $14,085 | 260,165 (Indirect Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 4:24 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
18,469 | $0.948 | $17,509 | 277,194 (Indirect Direct) |
View |
| 2023-08-14 Purchase |
2023-08-14 7:40 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
10,000 | $0.97 | $9,700 | 295,663 (Indirect Direct) |
View |
| 2023-03-13 Sale |
2023-03-13 9:21 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
7,562 | $1.53 | $11,570 | 191,663 (Indirect Direct) |
View |
| 2023-01-12 Sale |
2023-01-27 4:33 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
11,814 | $1.2 | $14,177 | 199,225 (Indirect Direct) |
View |
| 2022-09-12 Sale |
2022-09-13 6:48 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
18,159 | $0.6849 | $12,437 | 207,039 (Indirect Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 8:20 pm |
Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer |
1,252 | $1.25 | $1,565 | 170,272 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-30 Option Award |
2024-10-02 5:27 pm |
N/A 2034-09-29 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
150,224 | $0 | 150,224 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-20 6:47 pm |
N/A 2034-03-14 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
333,750 | $0 | 593,915 (Direct) |
View |
| 2023-03-27 Option Award |
2023-03-29 5:26 pm |
N/A 2033-03-26 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
270,000 | $0 | 461,663 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 5:07 pm |
N/A 2032-03-30 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
157,500 | $0 | 326,198 (Direct) |
View |
| 2021-12-29 Exercise |
2022-01-07 8:20 pm |
N/A 2027-09-17 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer |
2,101 | $0 | 170,272 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 9:23 pm |
N/A N/A |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
148,000 | $0 | 163,849 (Direct) |
View |
| 2021-07-30 Option Award |
2021-07-30 8:03 pm |
N/A 2031-07-29 |
Cidara Therapeutics Inc. | CDTX | Tari Leslie CHIEF SCIENTIFIC OFFICER |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2021-07-06 4:29 pm |
N/A N/A |
Cidara Therapeutics Inc. | CDTX | Tari Leslie Chief Scientific Officer |
0 | $0 | 389,662 (Direct) |
View |